Medical Research Finder

Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Oral Microbiome / Mouth Microbiota & Pancreatic Ductal Adenocarcinoma (PDAC) / Pancreatic Cancer

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Register for a free trial

Navigation

Contents

The human oral microbiome is a well‑established independent risk factor associated with the development of PDAC (Farrell et al. 2012 Gut 61: 582‑588; Michaud et al. 2013a Gut 62: 1764‑1770; Torres et al. 2015 PeerJ 3: e1373; Olson et al. 2017 Cancer Causes Control 28: 959‑969; Fan et al. 2018 Gut 67: 120‑127; Sun et al. 2020c Biomed Res Int 2020: 4712498; Vogtmann et al. 2020 Cancer Med 9: 797‑806), particularly Porphyromonas gingivalis, Neisseria elongata, Streptococcus mitis, and [Fusobacterium](br…

References (Sources)

Characterization of oral microbiome and exploration of potential biomarkers in patients with pancreatic cancer
Sun et al. 2020c Biomed Res Int 2020: 4712498
Human oral microbiome and prospective risk for pancreatic cancer: A population‑based nested case‑control study
Fan et al. 2018 Gut 67: 120‑127
Oral microbial community composition is associated with pancreatic cancer: A case‑control study in Iran
Vogtmann et al. 2020 Cancer Med 9: 797‑806
Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study
Michaud et al. 2013a Gut 62: 1764‑1770
Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review)
Huang et al. 2021d Int J Oncology 59: 101
Review
The microbiota and microbiome in pancreatic cancer: More influential than expected
Wei et al. 2019c Mol Cancer 18: 97
Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer
Farrell et al. 2012 Gut 61: 582‑588

AI Chat

7/1/2026

Chat with our artificial intelligence: